Literature DB >> 3931565

Reversible inhibition of central precocious puberty with a long acting GnRH analogue.

P S Ward, I Ward, A W McNinch, D C Savage.   

Abstract

A 7 year old girl with precocious puberty was treated with buserelin, a long acting analogue of gonadotrophin releasing hormone. Spontaneous and stimulated gonadotrophin secretion became prepubertal but returned to pubertal values when buserelin was withdrawn, suggesting that normal sexual maturation should follow cessation of treatment.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3931565      PMCID： PMC1777451          DOI： 10.1136/adc.60.9.872

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.

Authors:  P E Belchetz; T M Plant; Y Nakai; E J Keogh; E Knobil
Journal:  Science       Date:  1978-11-10       Impact factor: 47.728

2.  Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue.

Authors:  M D Donaldson; R Stanhope; T J Lee; D A Price; C G Brook; D C Savage
Journal:  Clin Endocrinol (Oxf)       Date:  1984-11       Impact factor: 3.478

3.  Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.

Authors:  M J Mansfield; D E Beardsworth; J S Loughlin; J D Crawford; H H Bode; J Rivier; W Vale; D C Kushner; J F Crigler; W F Crowley
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

4.  The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).

Authors:  R Stanhope; J Adams; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  1985-06       Impact factor: 3.478

5.  Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.

Authors:  F Comite; G B Cutler; J Rivier; W W Vale; D L Loriaux; W F Crowley
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245
  5 in total
  3 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Reversible inhibition of central precocious puberty with a long acting GnRH analogue.

Authors:  R Stanhope; P Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

3.  Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins.

Authors:  J L Rime; U Zumsteg; A Blumberg; F Hadziselimovic; J Girard; R P Zurbrügg
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.